Abstract
Human α1A-, α1B-, and α1D-adrenergic receptors were tagged at their amino termini with FLAG epitopes and stably expressed in human embryonic kidney (HEK)293 cells. Tagged receptors demonstrated a wild-type pharmacology and mobilization of intracellular Ca2+. After solubilization and immunoprecipitation, monomers, dimers, and trimers of each subtype were apparent on Western blots. Further denaturation with 6 M urea reduced most oligomers to monomers. Deglycosylation reduced the molecular size of α1A-, and to a lesser extent α1B- and α1D-adrenergic receptors. Radioligand binding site density was highest for α1A- and much lower for α1B- and α1D-adrenergic receptors, but did not correlate with protein expression. Commercial anti-α1-adrenergic receptor antibodies did not recognize the tagged receptors in Western blots of cell lysates, and substantial cross-reactivity was still observed after solubilization and immunoprecipitation. Surprisingly, only receptor monomers were apparent after photoaffinity labeling with 125I-arylazidoprazosin, and the intensity of photoaffinity-labeling correlated with the density of radioligand binding sites. We conclude that epitope-tagged α1-adrenergic receptors exist as both monomers and oligomers in HEK293 cells, but there is substantial discrepancy between protein and binding site expression. Because only monomers are detected by photoaffinity labeling, dimers and trimers observed on Western blots may be pharmacologically inactive.
Footnotes
-
This study was supported by the National Institutes of Health.
- Abbreviations:
- AR
- adrenergic receptor
- NE
- norepinephrine
- HRP
- horseradish peroxidase
- H/F
- hexahistidine FLAG
- DβM
- 4% n-dodecyl-β-d-maltoside
- PNGase F
- N-glycosidase F
- Ni2+-NTA
- Ni2+-nitriloacetic acid resin
- PAGE
- polyacrylamide gel electrophoresis
- aa
- amino acid(s)
- DTT
- dithiothreitol
- BMY7378
- 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride
- 125I-BE
- 125I-BE 2254
- Received January 14, 2002.
- Accepted March 7, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|